Breaking
DEStadtbahnen in Bonn nach Materialermüdung gesperrtTRİspanya'nın Zaferi Gazze'de Sevinç, Salamanca'da Trajediye DönüştüRUСилы ПВО перехватили и уничтожили 209 украинских БПЛА над Россией за ночьVNCảnh sát Texas giải cứu tài xế khỏi xe bốc cháyGLOBALIran's IRGC Claims Attack on Amazon Data Infrastructure in Bahrain Amid Escalating US-Iran HostilitiesDEUS verhängt 50-Prozent-Zölle gegen Kanada – Hockeyschläger, Wein und Zement betroffenJPGMO熊谷氏「在宅勤務廃止」発言を釈明 「作業はAIに任せ、人はオフィスに」USDeputy Sheriff Charged for Secretly Photographing Nude PrisonersINTLSudan Conflict Destabilizes Ethiopia, Threatening Refugees and Sparking Regional War FearsTROğuzhan Uğur ve 8 Şüpheli TutuklandıDEStadtbahnen in Bonn nach Materialermüdung gesperrtTRİspanya'nın Zaferi Gazze'de Sevinç, Salamanca'da Trajediye DönüştüRUСилы ПВО перехватили и уничтожили 209 украинских БПЛА над Россией за ночьVNCảnh sát Texas giải cứu tài xế khỏi xe bốc cháyGLOBALIran's IRGC Claims Attack on Amazon Data Infrastructure in Bahrain Amid Escalating US-Iran HostilitiesDEUS verhängt 50-Prozent-Zölle gegen Kanada – Hockeyschläger, Wein und Zement betroffenJPGMO熊谷氏「在宅勤務廃止」発言を釈明 「作業はAIに任せ、人はオフィスに」USDeputy Sheriff Charged for Secretly Photographing Nude PrisonersINTLSudan Conflict Destabilizes Ethiopia, Threatening Refugees and Sparking Regional War FearsTROğuzhan Uğur ve 8 Şüpheli Tutuklandı
Newsgather
BackCipla Reports 55% Drop in Q4 Net Profit, 26% Decline in FY26 PAT
Cipla Reports 55% Drop in Q4 Net Profit, 26% Decline in FY26 PAT
NEWS
Economic Times5/14/2026Business1 min readIndia

Cipla Reports 55% Drop in Q4 Net Profit, 26% Decline in FY26 PAT

Quick Look

  • Cipla's Q4 net profit drops 55% YoY to ₹555 crore, total income down 3% to ₹6,541 crore.
  • FY26 revenue up 2% to ₹28,163 crore, PAT declines 26% to ₹3,879 crore amid strong performance in key therapy areas.

AI-generated summary

Font size

Cipla announced a 55% drop in Q4 net profit to ₹555 crore and a 3% decrease in total income to ₹6,541 crore. For FY26, revenue grew 2% to ₹28,163 crore, but PAT declined 26% to ₹3,879 crore. MD Achin Gupta highlighted strong performance in key therapy areas and sustained growth in generics and consumer health. The board recommended a final dividend of ₹13 per equity share.

The company's performance was mixed, with challenges in profitability but strengths in specific business segments.

Related Topics

This article was originally published by Economic Times.

Related Stories

More on this topicCipla